Skip to content

Comprehensive Heart Failure Disease Management Community Program

Comprehensive Program for Disease Management in Heart Failure Patients in the Community

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00533013
Enrollment
1360
Registered
2007-09-21
Start date
2007-08-31
Completion date
2012-07-31
Last updated
2019-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The purpose of this study is to determine whether a nurse-led, comprehensive disease management program is effective in reducing recurrent hospital admissions and deaths in community dwelling patients with moderate to severe heart failure.

Detailed description

Heart failure remains a significant cause of death, in spite of recent declines in overall mortality from cardiovascular disease. Heart failure is associated with increasing costs for healthcare, mainly for recurrent hospital admissions. Disease management programs aimed to improve patients outcome while containing healthcare costs,were employed in heart failure patients with varying results. Such programs contain various components, including patient education and empowerment, monitoring patients' adherence to therapy, telemonitoring of vital parameters, etc. Designated heart failure clinics were also employed in care given to these patients.

Interventions

OTHERUsual Care

Management of heart failure is provided by primary practitioners and consultant cardiologists

OTHERDisease Management and Tele-Monitoring

Management of heart failure is provided by cardiologists at regional heart failure clinics and by nurse practitioners at regional heart failure clinics and a designated call center. Decisions on treatment are guided by designated protocols and information derived for tele-monitoring of blood pressure, body weight and pulse rate.

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patients with NYHA-Stage III-IV heart failure recruited in the community; 2. Adult patients with NYHA-Stage II-IV heart failure recruited after hospital admission for decompensated heart failure

Exclusion criteria

* Other severe disease (e.g. end stage renal disease, metastatic cancer); bedridden or severely compromised functional status due to other diseases; drug or alcohol abuse; Severe cognitive impairment; People unconnected to telephone

Design outcomes

Primary

MeasureTime frame
hospital admissions for heart failure or all-cause mortality5 years

Secondary

MeasureTime frameDescription
Health-related Quality of Life;5 yearsSF-36 score
Functional status5 years6-minute walk-test; NYHA classification category

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026